A panel discussion of controversies and challenges in the adjuvant treatment of colon cancer
Current issues of adjuvant therapy for colon cancer concern the introduction of drugs other than fluorouracil-5/leucovorin (5-FU/LV), the benefits for stage II patients, the use of new primary endpoints and the influence of age on treatment benefits. These issues were addressed in a panel discussion...
Saved in:
Published in | Clinical & translational oncology Vol. 7; no. 1; pp. 3 - 11 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
01.01.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!